FRANKLIN LAKES, N.J., March 5, 2026 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has obtained CE Marking for the Revello™ Vascular Covered Stent, a next-generation endovascular solution for the treatment of atherosclerotic lesions in the common and external iliac arteries. This advancement arrives at a pivotal moment, as lower‑extremity peripheral artery disease (PAD), which iliac artery disease is a key component—drives a substantial disability burden across the EU’s aging population.1,2 The Revello™ Vascular Covered Stent is designed to combine the flexibility of a nitinol self-expanding stent with the radial resistive force tailored for the iliac arteries.
Continue reading→